Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697207 | Brachytherapy | 2017 | 7 Pages |
Abstract
Interstitial HDR-BT was feasible and effective in the treatment of locally recurrent prostate cancer after definitive radiotherapy. The long-term toxicity was low and acceptable.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ping Jiang, Christof van der Horst, Bernhard Kimmig, Fabian Zinsser, Bjoern Poppe, Ulf Luetzen, Klaus-Peter Juenemann, Juergen Dunst, Frank-André Siebert,